Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhanot

Showing results (691-700 of 748) with videos related to

Pageof 75
Sort By:
Cell Metabolism|September 4, 2020
A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin ResistanceKun Lyu, Ye Zhang, Dongyan Zhang, et al.
The Journal of Clinical Investigation|August 24, 2018
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinomaChristof C Smith, Kathryn E Beckermann, Dante S Bortone, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2013
CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistanceJennifer L Cantley, Toru Yoshimura, Joao Paulo G Camporez, et al.
The Journal of Biological Chemistry|May 29, 2007
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistanceCheol Soo Choi, David B Savage, Ameya Kulkarni, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 29, 2024
Analysis of ASCL1/NEUROD1/POU2F3/YAP1 Yields Novel Insights for the Diagnosis of Olfactory Neuroblastoma and Identifies Sinonasal Tuft Cell-Like CarcinomaChristopher A Febres-Aldana, Mahmoud M Elsayad, Maelle Saliba, et al.
Hepatology (Baltimore, Md.)|November 24, 2012
Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in ratsNaoki Kumashiro, Toru Yoshimura, Jennifer L Cantley, et al.
Plos Genetics|August 23, 2012
Mutational signatures of de-differentiation in functional non-coding regions of melanoma genomesStephen C J Parker, Jared Gartner, Isabel Cardenas-Navia, et al.
Journal of the National Cancer Institute|November 21, 2017
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric CancerAnshuman Panda, Janice M Mehnert, Kim M Hirshfield, et al.
Molecular Metabolism|February 18, 2019
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in miceDaniel Lindén, Andrea Ahnmark, Piero Pingitore, et al.
Journal of Hepatology|January 11, 2025
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trialsJavier Armisen, Mitra Rauschecker, Janeli Sarv, et al.
Pageof 75

Showing results (691-700 of 748) with videos related to

Sort By:
Pageof 75
Cell Metabolism|September 4, 2020
A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin ResistanceKun Lyu, Ye Zhang, Dongyan Zhang, et al.
The Journal of Clinical Investigation|August 24, 2018
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinomaChristof C Smith, Kathryn E Beckermann, Dante S Bortone, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2013
CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistanceJennifer L Cantley, Toru Yoshimura, Joao Paulo G Camporez, et al.
The Journal of Biological Chemistry|May 29, 2007
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistanceCheol Soo Choi, David B Savage, Ameya Kulkarni, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 29, 2024
Analysis of ASCL1/NEUROD1/POU2F3/YAP1 Yields Novel Insights for the Diagnosis of Olfactory Neuroblastoma and Identifies Sinonasal Tuft Cell-Like CarcinomaChristopher A Febres-Aldana, Mahmoud M Elsayad, Maelle Saliba, et al.
Hepatology (Baltimore, Md.)|November 24, 2012
Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in ratsNaoki Kumashiro, Toru Yoshimura, Jennifer L Cantley, et al.
Plos Genetics|August 23, 2012
Mutational signatures of de-differentiation in functional non-coding regions of melanoma genomesStephen C J Parker, Jared Gartner, Isabel Cardenas-Navia, et al.
Journal of the National Cancer Institute|November 21, 2017
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric CancerAnshuman Panda, Janice M Mehnert, Kim M Hirshfield, et al.
Molecular Metabolism|February 18, 2019
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in miceDaniel Lindén, Andrea Ahnmark, Piero Pingitore, et al.
Journal of Hepatology|January 11, 2025
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trialsJavier Armisen, Mitra Rauschecker, Janeli Sarv, et al.
Pageof 75